The gastrointestinal side effects are consistent with GLP-1 receptor activation and are generally manageable with appropriate dosing strategies and patient education
#TMS #EEG #Neuroscience #BrainResearch #InterventionalPsychiatry To view or add a comment, sign in People living with epilepsy often have various psychiatric and wider somatic comorbidities, leading to the question epilepsy, and what else? Psychiatric disorders affect approximately one in three people with epilepsy and can be caused by biological as well as psychosocial factors
van AngelenAAGlaudemansBvan der KempAWCMHoenderopJGJBindelsRJM

When patients use both treatments concurrently, several precautions are warranted : Injection site management : Rotate sites systematically and avoid administering both injections in the same anatomical area on the same day Gastrointestinal monitoring : Tirzepatide's GI effects may be misattributed to lipotropic injections, potentially leading to inappropriate dose adjustments Hydration emphasis : Ensure adequate fluid intake given tirzepatide's potential to cause dehydration through GI effects Medication adjustments : Consider reducing doses of insulin or sulfonylureas when initiating tirzepatide to mitigate hypoglycemia risk Realistic expectations : Counsel patients that weight loss benefits derive primarily from tirzepatide's pharmacological action Cost considerations : Lipotropic injections represent additional out-of-pocket expense without proven incremental benefit Patients should seek immediate medical attention for severe or persistent abdominal pain (possible pancreatitis), right upper quadrant pain with fever or jaundice (gallbladder disease), signs of allergic reaction, persistent vomiting leading to dehydration, or symptomatic hypoglycemia if on insulin/sulfonylureas

it's about diving deep into the cellular environment where these growths originate